Bhumsuk Keum

59PUBLICATIONS
264CO-AUTHORS
Molecular targetsCounselling psychologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Sep 15, 2026
Amivantamab plus pembrolizumab in previously untreated recurrent/metastatic head and neck squamous cell cancer: Results from the phase 1b/2 OrigAMI-4 study.

|Aug 31, 2026
Central Nervous System Activity of Lazertinib in EGFR-Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG-LU20-15 and LU21-01.

|Aug 28, 2026
Addressing Existential Distress Through Compassion: Feasibility and Preliminary Effects of Compassion With You (COMwithU), a Compassion-Based Intervention for Patients With Cancer.

|May 21, 2026
Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19-09, CONPELAN Study.

|Apr 10, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

Bhumsuk Keam, Darren Wan-Teck Lim, Hsiang-Fong Kao

|Feb 10, 2026
Clinical Characteristics Associated with High [68Ga]Ga-PSMA-11 Uptake and Preliminary Therapeutic Outcomes in Patients with Metastatic Adenoid Cystic Carcinoma.

Hyunpil Sung, Minseok Suh, Joonhyung Gil

Pageof 10

Frequent Collaborators

14 joint publications

Shin Hyu Yoo

7 joint publications

Yoon Kyung Jeon

7 joint publications

Myung-Ju Ahn

6 joint publications

Miso Kim